JENNIFER CURATI: Open Payments
NPI 1154795318 · HUDSON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 35 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $684
Food & beverage: $684
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $153 |
| Novo Nordisk Inc | 6 | $91 |
| Exact Sciences Corporation | 4 | $89 |
| ABBVIE INC. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $27 |
Products named: FARXIGA, Cologuard Collection Kit, Ozempic, CREON, ELIQUIS, TRELEGY ELLIPTA, GEMTESA, XIFAXAN.
Industry payments across OH — which companies pay providers there.
